Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

ebi-pharm ag - candida albicans d 12, 0,33 mg / 1 ml; candida parapsilosis, d12, 0,33 mg / 1 ml; penicillium roqueforti, d12, 0,33 mg / 1 ml - tropfen / spray - d - candida albicans, d12, 0,33 ml / 1 ml; candida parapsilosis, d12, 0,33 ml / 1 ml; penicillium roqueforti, d12, 0,33 ml / 1 ml - homöopathisch

Canada - français - Health Canada

green health - candida parapsilosis - liquide - 30c - candida parapsilosis 30c - homeopathic products

Union européenne - français - EMA (European Medicines Agency)

amgen europe b.v. - blinatumomab - cellule précurseur leucémie lymphoblastique - lymphome - agents antinéoplasiques - blincyto is indicated as monotherapy for the treatment of adults with cd19 positive relapsed or refractory b precursor acute lymphoblastic leukaemia (all). patients with philadelphia chromosome positive b-precursor all should have failed treatment with at least 2 tyrosine kinase inhibitors (tkis) and have no alternative treatment options. blincyto is indicated as monotherapy for the treatment of adults with philadelphia chromosome negative cd19 positive b-precursor all in first or second complete remission with minimal residual disease (mrd) greater than or equal to 0. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with philadelphia chromosome negative cd19 positive b precursor all which is refractory or in relapse after receiving at least two prior therapies or in relapse after receiving prior allogeneic haematopoietic stem cell transplantation. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with high-risk first relapsed philadelphia chromosome negative cd19 positive b-precursor all as part of the consolidation therapy (see section 4.

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

ebi-pharm ag - candida albicans e volumine cellulae (lyophil., steril.) d5 (hab 5a), candida parapsilosis e volumine cellulae (lyophil., steril.) d5 (hab 5a), penicillium roqueforti e volumine cellulae (lyophil., steril.) d5 (hab 5a) - buvable en gouttes et frotter - zulassung gilt auch für alle höheren folgepotenzen: candida albicans e volumine cellulae (lyophil., steril.) d5 (hab 5a) 0.334 ml, candida parapsilosis e volumine cellulae (lyophil., steril.) d5 (hab 5a) 0.334 ml, penicillium roqueforti e volumine cellulae (lyophil., steril.) d5 (hab 5a) 0.334 ml, aqua purificata, ad solutionem pro 1 ml, corresp. 22 guttae. - zulassung mit reduziertem dossier ohne indikation nach art. 25 abs. 1 kpav (sr 812.212.24) - les médicaments homéopathiques

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

ebi-pharm ag - candida parapsilosis e volumine cellulae (lyophil., steril.) (hab 5a) - buvable en gouttes et frotter - zulassung gilt auch für alle höheren folgepotenzen: candida parapsilosis e volumine cellulae (lyophil., steril.) (hab 5a) 1 ml, aqua purificata, ad solutionem pro 1 ml, corresp. 21 guttae. - zulassung mit reduziertem dossier ohne indikation nach art. 25 abs. 1 kpav (sr 812.212.24) - les médicaments homéopathiques

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

ebi-pharm ag - candida parapsilosis e volumine cellulae (lyophil., steril.) d4 (hab 6) - gélules - zulassung gilt auch für alle höheren folgepotenzen: candida parapsilosis e volumine cellulae (lyophil., steril.) d4 (hab 6) 330 mg, lactosum monohydricum 330 mg, kapselhülle: hypromellosum, pro capsula. - zulassung mit reduziertem dossier ohne indikation nach art. 25 abs. 1 kpav (sr 812.212.24) - les médicaments homéopathiques

Canada - français - Health Canada

ipsen biopharmaceuticals canada inc - mécasermine - solution - 40mg - mécasermine 40mg - somatotropin agonists*

Canada - français - Health Canada

novartis pharmaceuticals canada inc - inclisiran (inclisiran sodique) - solution - 284mg - inclisiran (inclisiran sodique) 284mg

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

laboratoire homéopathique d. schmidt-nagel sa - candida albicans - tropfen / spray, globuli - k30, d; c12, d; d24, d; lm/f5, d - homöopathisch

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

omida ag - candida albicans - tropfen / spray, globuli, tabletten - c12, d; lm/f5, d; k30, d; d24, d - homöopathisch